Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3)

Clinical trial NCT01515007 · COMPLETED

Trial details

NCT number: NCT01515007
Sponsor: Aradigm Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non Cystic Fibrosis Bronchiectasis

Start date: 2014-03-31
Primary completion: 2016-08-17
Enrollment: 278

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.